Medicine
Epifoam 100 mg/100 mg per 10 g foam
Epifoam 100 mg/100 mg per 10 g foam is a prescription medicine containing Hydrocortisone and Pramoxine for topical use, marketed by Viatris Specialty, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
DO NOT REFRIGERATE. Store upright at controlled room temperature 20° – 25°C…
Key facts
- Active ingredient (INN)
- Hydrocortisone and Pramoxine
- Brand
- Epifoam
- Strength
- 100 mg/100 mg per 10 g
- Dosage form
- Foam
- Route
- Topical
- Packs
- 1 canister
- Marketing authorisation holder
- Viatris Specialty
- Manufacturer
- Viatris Specialty
- Origin register
- US FDA, United States
- Storage
- DO NOT REFRIGERATE. Store upright at controlled room temperature 20° – 25°C (68° – 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 25 August 2014
- Identifiers
- RxCUI 904782, 904783DailyMed set ID b22b8b41-2f1e-11e4-8c21-0800200c9a66NDC 0037-6824Application ANDA086457
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 canister in 1 carton / 10 g in 1 canister | 0037-6824-10 | Viatris Specialty | 25 August 2014 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | Approved | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Hydrocortisone and Pramoxine 100 mg/100 mg per 10 g foam.
Other strengths and forms of Hydrocortisone and Pramoxine
Clinical summary
Hydrocortisone and Pramoxine is a fixed-dose combination medicine indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. It is available as cream, lotion and foam for topical use. MedsAcross supplies Hydrocortisone and Pramoxine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Hydrocortisone and PramoxineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Analpram HC prescribing information (Legacy Pharma) · U.S. National Library of Medicine, DailyMed
Need Epifoam 100 mg/100 mg per 10 g foam for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.